📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
57
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split
55%
• 50-day avg $0.98 below $1 exchange minimum
💹 Market Data
Market Cap$40.55M
Shares Outstanding72.61M
Float25.50M
Cash$133.6K
Debt$15.56M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 98.3% shares (2025Q4 vs prior)
1 institutional holders · 116 shares
#1
UBS Group AG
116 shares
📉 Short Interest
Short Interest15.7K
Days to Cover2.5
% of Float0.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Jun 30, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SCAG
📊 SCAG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SCAG Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.